Gene Query: FDFT1

Dataset Description Geneva Score
Targeting EZH2 in MYCN-amplified Neuroblastoma [RNA-seq] 114.74
Targeting EZH2 in MYCN-amplified Neuroblastoma 114.74
Grainyhead-like 2 (GRHL2) and epigenetic remodeling in the intermediate states of epithelial-mesenchymal transition [RNA-seq] 97.51
Grainyhead-like 2 (GRHL2) and epigenetic remodeling in the intermediate states of epithelial-mesenchymal transition 97.51
Molecular Mechanisms of Endothelial Hyperpermeability 85.46
Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function 85.38
RNA-seq analysis of the role of HBO1 (KAT7/MYST2) in the ovarian cancer cell line UWB1.289. 75.2
RNA-Seq to assess the transcriptional effects of G quadruplex stabilization by the G4 ligand PhenDC3 in HT-1080 cells 68.23
Nuclear Actin Regulates Inducible Transcription by Enhancing RNA Polymerase II Clustering 64.73
Axitinib exposure triggers endothelial cells senescence through ROS accumulation and ATM activation 59.33
The effects of chemokines CCL2/7 on MDA-MB-231-FOXC1 cells 58.01
A role for p53 in the adaptation to glutamine starvation through the expression of Slc1a3 51.43
Differentially Expressed Genes upon Knockdown of ZRANB1 or EZH2 in LM2 Cells 48.0
Effects of Cardiac Glycosides on RNA Expression in Prostate Cancer LNCaP-abl Cells 47.38
UBE3A-mediated regulation of imprinted genes and epigenome-wide marks in human neurons 47.37
A transcriptional regulatory network connects mitochondrial biogenesis and metabolic shift with stem cell commitment to hepatic differentiation 46.04
Tracking transcriptional changes in a species-specific manner during experimental hepatoblastoma progression in vivo 44.24
Divergent effects of eRF3 and Upf1 on the expression of uORF carrying mRNAs and ribosome protein genes 43.29
RNA-Seq analysis of breast cancer cells after shikonin treatment 38.87
Next generation sequencing of human hepatic stellate cell line, LX-2 treated with recombinant human TGF-β1, with DMSO or ML290 (5 µM) for 72h. 38.31
Effect of OVO-like 1 knockdown on global transcript expression in differentiated BeWo trophoblast cells 37.78
Functional studies of missense TREM2 mutations in human stem cell-derived microglia 37.37
Genome-wide view of the impact of Spt5-Pol II inhibitors (SPIs) on mRNA levels [RNA-Seq 24h] 37.36
Transcriptome profile of ATP7B KO cells and WT cells treated with Copper (Cu) to study Autophagy as a pro-survival mechanism in Wilson disease 36.61
ETS1 acts as a tumor suppressor in breast cancer by inhibiting growth-related factors 35.89
Transcriptome Profiling of Influenza A Virus-infected Lung Epithelial (A549) Cells with Lariciresinol-4-β-D-glucopyranoside Treatment 35.81
XPO1 inhibition antagonizes MCL via nuclear retention of IkB: Selinexor demonstrates antitumor activities in both ibr-sensitive and ibr-resistant tumor cells 35.49
Sauchinone controls hepatic cholesterol homeostasis by the negative regulation of PCSK9 transcriptional network 35.22
Genome-wide maps of m6A circRNAs identify widespread and cell-type-specific methylation patterns that are distinct from mRNAs 34.52
Integrated multi-omics approach reveals a role of ALDH1A1 in lipid metabolism in human colon cancer cells 34.14
Ribosome profiling of A549 cells depleted of RPLP1 and RPLP2 and infected with DENV. 32.76
Strand-specific Dual RNA-seq of Bronchial Epithelial cells Infected with Influenza A/H3N2 Viruses Reveals Splicing of Gene Segment 6 and Novel Host-Virus Interactions 32.25
Sensing self and nonself circular RNAs 31.58
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer [RNA-Seq] 31.19
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer 31.19
RNA-seq Analysis of Castration-Resistant Prostate Cancer With Knock-down of E2F1 31.18
RNA Sequencing Reveals Immunosuppressive Role of Anthrax Lethal Toxin in Human Lung Epithelial and Monocytic Cells 30.77
An RNA-centric dissection of host complexes controlling flavivirus infection 30.48
An RNA-centric dissection of host complexes controlling flavivirus infection [RNA-Seq] 30.48
Ribo_seq (aka ribosome profiling) analysis of control and Myc-induced U2OS cells 30.45
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 30.27
Improved genome-wide mapping of uncapped and cleaved transcripts in eukaryotes—GMUCT 2.0 29.74
SIRT7 Antagonizes TGF-β Signaling and Inhibits Breast Cancer Metastasis 29.64
NOTCH1 activation in breast cancer confers sensitivity to inhibition of SUMOylation 29.34
Nm-seq finds thousands of modified 2’-O-methylation sites in mRNA with base precision 29.34
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer 27.94
Maintaining iron homeostasis is the key role of lysosomal acidity for cell proliferation 27.61
RNA sequencing (RNA-SEQ) of EPAS1 knockdown by siRNA in endothelial cells 27.6
Effect of MDK expressing Melanoma cells conditioned media in Human LEC 27.48
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer [RNA-Seq] 27.47
Stably-paused genes revealed through inhibition of transcription initiation by the TFIIH inhibitor Triptolide 26.8
RNA sequence analysis of stable versus reversible EMT events and the resultant metastases 26.72
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 26.53
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 26.53
β-catenin/Tcf7l2 dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer 26.29
RNA-seq in transgenic cells 25.74
Nudt3 is a mRNA Decapping Enzyme That Modulates Cell Migration 25.69
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 25.06
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] 25.06
Transcriptome variation among human embryonic stem cell lines impacts on their differentiation 24.47
Expression analysis of Mebendazole treated THP-1 cells in three paired samples 23.98
Identification of Sin3B regulated genes during quiescence 23.95
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice [HCT116_RNA-seq] 23.76
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice 23.76
Cellular gene expression during Hepatitis C Virus replication revealed by Ribosome profiling 23.5
Differentially expressed vascular development genes for iPSC-ECs from CDI 23.47
Fisetin induces autophagy in pancreatic cancer cells via endoplasmic reticulum stress- and mitochondrial stress-dependent pathways 23.38
Genome-wide RNA-seq from GALNT14-depleted and GALNT14 overexpressing MDA-MB-231 LM2 and Par cells 23.16
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock [RNA-Seq] 22.85
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock 22.85
Transcriptome-wide study of the response of human trabecular meshwork cells to the substrate stiffness increase 22.8
Limiting cholesterol biosynthetic flux engages type I IFN signaling in a STING-dependent manner 22.63
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [BAA] 22.32
Knockout of miR-221 and miR-222 reveals overlapping and specific function between paralogous miRNAs 22.21
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 22.2
Statins modulate endothelial transcriptional profile by inhibiting EZH2 22.09
RNA-Seq data of NCI-H82 cells expressing a Dox-On pRB (pTripZ RB1) grown in the presence or absence of DOX and then treated with vehicle or AZD2811. 22.03
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 21.96
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 [RNA-seq] 21.96
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 21.91
RNA-seq analyisis of PUM2 knockout cells 21.85
Role for citron kinase in prostate cancer growth 21.76
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [cPDS-RNA-seq] 21.55
Genome-wide analysis of YAP and TFCP2 occupancy and regulated expression in liver cancer cells 21.5
Genome-wide analysis of YAP and TFCP2 down-regulated genes in liver cancer cells 21.5
Expansion of adult human pancreatic tissue yields organoids harbouring progenitor cells with endocrine differentiation potential 21.26
Knockdown of ADNP in HCT116 colon cancer cells 21.26
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes 21.07
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes [seq] 21.07
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [polyA RNA-seq] 20.95
Treatment of SW480 colon cancer cell induced xenografts with AZD and DBZ 20.88
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and AXL-/- astrocytes Transcriptomes 20.87
Differential responses of human fetal brain neural stem cells to Zika virus infection 20.72
Transcriptional profiling of MCF7 cells treated with H3B05942, E2, or standard of care compounds 20.67
Treatment Paradigms for Retinal and Macular Diseases Using 3-D Retina Cultures Derived From Human Reporter Pluripotent Stem Cell Lines 20.53
Food-derived Compounds Apigenin and Luteolin Modulate mRNA Splicing of Introns with Weak Splice Sites 20.11
Regionally distinct astrocyte interferon signaling promotes blood-brain barrier integrity and limits immunopathology during neurotropic viral infection 20.1
MUC1-C represses the RASSF1A tumor suppressor and activated Kras signaling in human carcinoma cells 20.0
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress [human] 19.63
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress 19.63
Gene expression analysis of the impact of TDP-43 knockout in human cells. 19.36
ZIKV infection of monocytes activates inflammasome pathways 19.13
mRNA-sequencing of U87 glioblastoma and DAOY medulloblastoma spheroidal aggregates undergoing electrotaxis 19.09
Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing 19.02
RNA-sequencing (RNA-seq) in BxPC-3 and S2-007 cell lines 18.87
Transcriptome analysis in Neobractatin treated cells 18.84
Circular RNAs in the mammalian brain are highly abundant, conserved, and dynamically expressed 18.82
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence 18.8
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence [RNA-Seq] 18.8
The mechanism of HHT in treating acute myeloid leukemia on RNA level. 18.71
Transcriptional Profiling Identifies Novel Regulators of Macrophage Polarization [RNA-Seq] 18.45
Transcriptional Profiling Identifies Novel Regulators of Macrophage Polarization 18.45
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion 18.28
MPTAC determines APP fragmentation via sensing sulfur amino acid catabolism 18.25
Genomic basis for clinical response to histone deacetylase inhibition in advanced urothelial carcinoma 18.22
Effect of mitochondria deficiency on senescence-associated gene expression 18.17
A TGFbeta-PRMT5-MEP50 Axis Regulates Cancer Cell Invasion through Histone H3 and H4 Arginine Methylation Coupled Transcriptional Activation and Repression 17.99
Effect of CRISPR-Cas9 mediated knock-out of integrin alpha2 on the transcriptome of DU145 prostate cancer cell grown as a spheroid culture 17.95
SHQ1 regulation of RNA splicing is required for T-lymphoblastic leukemia cell survival 17.88
Identification of ZEB1-regulated gene expression changes in HCC827 human lung adenocarcinoma cells 17.86
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies [RNA-Seq] 17.85
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies 17.85
RNA-Seq following PCR-based sorting reveals rare cell transcriptional signatures 17.77
R430: A potent inbibitor of DNA and RNA viruses 17.7
RG/RGG boxes are common binding motifs in RNA-G-quadruplex-interacting proteins 17.68
Next Generation Sequencing Facilitates Quantitative Analysis of ALDH+ E-BCSC, CD24-CD44+ M-BCSC and Bulk tumor cell Transcriptomes from MC1 and Vari068 PDX models of TNBC 17.45
RNA expression following TMPRSS11B overexpression or depletion 17.29
Genes altered in expression by Cisplatin treatment in lung cancer cell lines 17.17
JQ1 +/- Vemurafenib in BRAF mutant melanoma (A375) 17.16
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line 17.08
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element 17.08
Analysis of Combined Transcriptomes Identifies Gene Modules Differentially Responding to Pathogenic Stimulation in Vascular Smooth Muscle and Endothelial Cells 17.04
Overexpression of UGT2B17 in MEC1 and JVM2 leukemia cell lines 16.99
Evolving Spindlin1 Small Molecule Inhibitors Using Protein Microarrays 16.61
Gene expression profiles in response to proanthocyanidins in pancreatic cancer cells 16.55
Trans-chromosomal regulation by a novel lincRNA required for adipogenesis that escapes X-chromosome inactivation 16.54
Retinoic acid suppresses MYB in adenoid cystic carcinoma [RNA-seq] 16.53
Retinoic acid suppresses MYB in adenoid cystic carcinoma 16.53
RNA-seq analyses of human prostate cancer cells 16.49
Differential Gene Expression between MCF10A and MCF7 cells 16.39
Heterozygous p53-R280T mutation promotes proliferation of NPC cells through activating PI3K/Akt signaling pathway 16.33
HMGA1 and FOXM1 synergistically regulate a common gene network modulating angiogenesis in breast cancer 16.25
Activation of Wnt/beta-catenin in Ewing sarcoma cells antagonizes EWS/ETS function and promotes phenotypic transition to more metastatic cell states 16.23
DNMT and HDAC inhibitors globally induce cryptic TSSs encoded in long terminal repeats 16.21
Next Generation Sequencing of isolated EGFR+ and HLA-G+ first trimester human trophoblasts 16.18
RNA sequence of mRNA in HUVEC cells after depleting EGFL6 15.9
Genome wide mapping of polyadenylation sites in proliferating and contact-inhibited cells and cells with knockdown of cleavage and polyadenylation factors 15.87
CD95L derived si- and shRNAs and the CD95L mRNA kill cancer cells through an RNAi mechanism by targeting survival genes [siL3.RNAseq.lg] 15.86
Tumors with TSC mutations are sensitive to CDK7 inhibition through NRF2 and glutathione depletion 15.77
Metformin induces chromosome reorganization and changes in gene expression in normal human fibroblasts 15.64
Transcriptional profiling of MDA-MB-231 and its ρ0 cells (lacking mtDNA) after 48h arginine depletion by arginine deiminase (ADI). 15.63
Gene expression changes upon drug withdrawal (Mel888 cell line) 15.59
LINC00520 is Induced by Src, STAT3, and PI3K and Plays a Functional Role in Breast Cancer 15.55
STRIPAK directs PP2A activity to promote oncogenic transformation 15.49
Dtx3L and Androgen Signaling in Prostate Cancer 15.46
Solid phase chemistry to covalently and reversibly capture thiolated RNA 15.45
RNA-seq in LNCaP cell line overexpressing WT or mutant FOXA1 15.36
Forkhead domain mutations in FOXA1 drive prostate cancer cell progression 15.36
Epigenetic siRNA and chemical screens identify SETD8 inhibition as a new therapeutic strategy of p53 reactivation in high-risk Neuroblastoma. 15.3
RNA-seq data from human SGBS adipocytes differentiated with marine oxohexadecenoic acids 15.21
Next generation sequencing on knockdown of AC093323.3 in lung cancer cells 15.09
Comprehensive comparative analysis of RNA sequencing methods for degraded or low input samples 14.99
Human iPSC-based Modeling of Late-Onset Disease using Progerin-induced Aging 14.97
Trans-differentiation of human adult peripheral blood T cells into neurons 14.93
Next Generation RNA Sequencing Analysis of AMPK Wild Type, AMPKα-KO and AMPKα1-2A U2OS cell Transcriptomes 14.86
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) 14.69
Gene expression profiling of KSHV-infected periodontal ligament cells 14.68
CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal transition-like transcriptional activation 14.66
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress 14.66
Transcriptome analysis of ECFCs treated with GSK-343 and Panobinostat 14.49
Microsatellite expansion RNA visualization, elimination, and reversal of molecular pathology by RNA-targeting Cas9 14.39
Ribosome queuing enables non-AUG translation to be resistant to multiple protein synthesis inhibitors 14.31
Transcriptomic profiling discloses molecular and cellular events related to neuronal differentiation in SH-SY5Y cells 14.21
Adipocyte-derived lipids mediate melanoma progression via FATP proteins 14.16
High level DNA repair gene expression in human ES cells 14.02
Pancreatic cancer-derived exosomes induce apoptosis of T lymphocytes through the p38 MAPK signal transduction pathway 14.01
RNA sequencing of 13 T-cell acute lymphoblastic leukemia patients (5 TCRAD-MYC translocated T-ALL_8TAL1-LMO2 T-ALL) 13.99
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [ESRP KD] 13.95
Transcriptomic characterization of a human in vitro model of arrhythmogenic cardiomyopathy under topological and mechanical stimuli 13.83
Gene expression profiling of human and murine in vitro muscle differentiation 13.77
Comparative Transcriptome analysis of hESCs- and iPSCs-derived lentoid body 13.73
RNA-seq of human fibroblasts after irradiation 13.72
HeLa transcriptome induction by IFN gamma and indoleamine 2,3-dioxygenase (IDO) 13.7
Transcriptomic profiling of HeLa cells infected with Salmonella Typhimurium 13.69
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis [MultiDisease] 13.67
Triplet nucleotide repeat-based siRNAs are highly toxic to cancer cells 13.66
Gene Expression Profiling of SPOP Knocked Down Cell 13.63
Inhibition of the Aryl Hydrocarbon Receptor - Polyamine Biosynthesis Axis Suppresses Multiple Myeloma and prostate cancer progression 13.61
RNA m5C Methylation in breast cancer using MeRIP-Seq 13.61
Searching for target genes of miR-508/509/506/514 in HCT116 cells 13.58
PolyA-sequencing in Kelly and Kelly E9R neuroblastoma cells treated with THZ531 or DMSO 13.55
In vitro differentiation of human embryonic stem cells into ovarian follicle-like cells 13.5
Modeling the MYC-driven normal-to-tumour switch in breast cancer. 13.4
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export II 13.39
Generation, transcriptome profiling, and functional validation of cone-enriched human retinal organoids 13.38
ERBB3 and NGFR mark distinct skeletal muscle progenitor cells in human development enabling enrichment and maturation of hPSC muscle 13.28
Epigenomic landscape during organ formation in human early embryos 13.12
The MLL-AF9 and MLL-AF4 oncofusion proteins bind a distinct enhancer repertoire and target the RUNX1 program in MLLr AML 13.09
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation 13.07
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation (RNA-Seq) 13.07
To investigate the decay constants (half-lives) of transcript isoforms generated by alternative polyadenylation in proliferating and quiescent cells 13.06
CD97 is a Critical Regulator of Acute Myeloid Leukemia Stem Cell Function 13.06
KSDM1b Role in Ewing Sarcoma 13.02
Contribution of SRF and Nkx2-5 to androgen-dependent gene expression in prostate cancer 13.02
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis [RNA-Seq] 13.0
Differential expression of genes in AD169-infected MRC5. 12.88
RNA sequencing of primary human platelets and in vitro cell lines 12.83
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques 12.82
Pericyte-like cells generated from human pluripotent stem cells support hematopoietic stem and progenitors ex vivo 12.79
PTEN suppresses neoplastic transformation of human neural stem cells by transcriptional repression of Pax7 12.77
MYCi975 regulates MYC target genes 12.72
Hit-and-run' programing of CAR-T cells using mRNA nanocarriers 12.68
Irf9 function in immunity in mouse 12.64
Transcription profile analysis of wild type and Irf9-/- human monocytic THP1 cells in response to type I interferons 12.64
The ribosomal prolyl-hydroxylase OGFOD1 decreases during cardiac differentiation, modulates translation and spliceosomal processes 12.58
Profiling of gene expression using RNA-Seq in fibroblasts, iPSCs, iPSC-derived neurons and cells overexpressing Onecut transcription factors 12.54
Changes in chromatin accessibility and gene expression induced by overexpression of ONECUT transcription factors 12.54
Single-cell RNA-Seq Investigation of Foveal and Peripheral Expression in the Human Retina 12.54
Cell Type-Specific Chromatin Signatures Underline Regulatory DNA Elements in Human Induced Pluripotent Stem Cells and Somatic Cells 12.52
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex 12.46
The DPYSL2 gene connects mTOR and schizophrenia 12.45
Epithelial-mesenchymal transition markers screenedina cell-based model and validated in lung adenocarcinoma 12.45
Next Generation Sequencing Facilitates Quantitative Analysis of Human Pluripotent Stem Cell-Derived Endocardial-like And Primary Cardiac Endothelial Cell Transcriptomes 12.43
A Druggable TCF4- and BRD4-dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm (RNA-Seq) 12.42
A SIRT1-centered Circuitry Regulates Breast Cancer Stemness and Metastasis 12.38
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [mutant MEF2C] 12.37
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation 12.34
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation (Human_RWPE1_RNA-Seq) 12.34
Safeguarding nucleolar homeostasis by CBX4 alleviates senescence and osteoarthritis 12.33
RNAseq to determine gene expression changes following depletion of SETDB1 in THP-1 AML Cells 12.29
Differentiation of human embryonic stem cells to HOXA+ hemogenic vasculature that resembles the aorta-gonad-mesonephros 12.27
Innate-like activation of mucosal-associated invariant T cells in mycobacterial infection 12.24
Identifying the molecular mode of action of itraconazole in colorectal cancer 12.1
Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine resistant breast cancer 12.05
Epigenetic reprogramming at estrogen-receptor binding sites alters the 3D chromatin landscape in endocrine resistant breast cancer [RNA-seq] 12.05
MYCL and EP400 are required for Max and MCPyV mediated gene activation 12.02
RNA-seq and flow-cytometry of conventional, scalp, and palmoplantar psoriasis reveal shared and distinct molecular pathways 11.99
Gene expression profile using RNA-seq in WC00060 or SR-0788 cells transfected with siRNA for KPC1 or control 11.98
CHCHD10 gene KO effect in iPSC drived motor neurons 11.91
Comparative gene expression profiling of human primary endotheliocytes cultivated on polyurethane-based electrospun 3D matrices and natural decellularized vein 11.89
TRIM24 is an oncogenic transcriptional co-activator of STAT3 in glioblastoma 11.84
Bioreactor-engineered cancer tissues mimic phenotypes, gene expression profiles and drug resistance mechanisms detectable in xenografts and clinical specimens. 11.78
B cells expressing the IgA receptor FcRL4 participate in the autoimmune response in patients with rheumatoid arthritis 11.76
Evolution of a transcriptional regulator from a transmembrane nucleoporin 11.74
RNA-seq in HepG2 and IMR90 cells 11.74
FOXD3 is a novel tumor suppressor in lung cancer 11.7
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HET] 11.66
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 11.63
Epigenomic profiling reveals the key function of histone H3K9 methylation during tumor transformation process 11.61
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation [RNA-Seq] 11.59
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation 11.59
Splicing and gene expression changes in human MDAM-MB231 breast cancer cells with TRA2B knockdown 11.56
Differential gene expression of static and intermittent compressive force treated human periodontal ligament cells 11.56
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 11.52
RNA sequencing (RNA-SEQ) of Human endothelial cells (HUVEC) in LFS, sFRP2OE, and WT conditioned media 11.49
Ex vivo expanded human 3D Nephrospheres engraft long term and repair chronic renal injury in mice 11.45
Transcriptomic Alterations in Lung Adenocarcinoma Unveil New Mechanisms Targeted by the TBX2 Subfamily of Tumor Suppressor Genes 11.37
A Werner syndrome stem cell model unveils heterochromatin alterations as a driver of human aging 11.3
Effect of hypoxia and TGFβ1 on gene expression in HPF fibroblast cells 11.18
A cell-permeable stapled peptide inhibitor of the estrogen receptor/coactivator interaction 11.15
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (human 3' mRNA-seq) 11.14
RNASeq of 4SU labelled nascent RNA in MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 11.14
JAK2 is dispensable for maintenance of JAK2 mutant B-cell acute lymphoblastic leukemias 11.06
Comparative gene expression profiling of MHH-CALL4 cells subject to pharmacological JAK2 inhibitor treatment (ruxolitinib or CHZ868) or shRNA-mediated JAK2 depletion in vitro 11.06
GIST cell cycle dysregulation is required for progression to high-risk disease but not for resistance to kinase inhibitors 11.0
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation 10.97
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation (RNA-seq) 10.97
Overexpression and knockdown experiment for circCSNK1G3 10.96
The CDK7 Inhibitor THZ1 Alters RNA Polymerase Dynamics at the 5’ and 3’ Ends of Genes 10.94
Structure and degradation of circular RNAs regulate PKR activation in innate immunity 10.82
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages 10.79
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages (RNA-Seq, CAGE and ChIP-Seq) 10.79
Transcriptomic insights into human decidual and peripheral blood CD8 T cells 10.79
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment 10.75
Cleavage Factor Im as a key regulator of 3’ UTR length 10.72
RNA-seq analysis of CRISPR/Cas9 generated human BMPR2 deficient endothelial cell lines harboring mutations characteristic for hereditary pulmonary hypertension (HPAH) 10.69
RNASeq of MV4;11 cells transduced with scramble shRNA or BRD4 shRNA in combination with DMSO or SGC0946 10.65
Proteolytic cleavage by taspase1 and the regulation of the stability of MLL1 10.52
Functional TRIM24 degraders via conjugation of ineffectual bromodomain and VHL ligands [RNA-seq] 10.5
Gene expression in PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition. 10.47
PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition 10.47
Modulation of mitochondrial DNA copy number to induce hepatocytic differentiation of human Amniotic Epithelial cells 10.44
Transcriptome sequencing of differentially expressed genes in acne inversa (AI) patients with NCSTN mutation and healthy individuals 10.33
Transcriptome sequencing of differentially expressed genes in mouse and human skin with and without NCSTN mutation 10.33
mRNA Sequencing of Human PromoCells Using Random Primed mRNA-Sequencing Technique 10.28
Circular RNA expression signature of low-glucose-treated MIA PaCa-2 cells 10.24
CSL RNA-Seq on HKC and SCC cell lines 10.2
CSL 10.2
Modeling Familial Cancer with iPSC Approaches 10.15
EGFR Mutation Promotes Glioblastoma Through Epigenome and Transcription Factor Network Remodeling 10.15
Global analyses of the effect of different cellular contexts on microRNA targeting (RNA-Seq) 10.06
Global analyses of the effect of different cellular contexts on microRNA targeting 10.06
Bulk RNA-sequencing of cell types isolated by FACS from normal human prostates 9.94
Exploring transcriptomic landscapes in red cell populations, in their extracellular vesicles and on single cell level 9.93
Proteinase-Activated Receptor 4 (PAR4) mediates cell membrane blebbing in a Gaq/11, Gai independent, RhoA and ß-arrestin-dependent manner. 9.91
Genome-wide analysis of Dengue virus 2 infected cells 9.9
Transcriptome analysis reveals differential splicing events in IPF lung tissue 9.9
Transcriptome analysis of human immortilized astrocytes reprogrammed into dopaminergic neurons 9.88
Mitochondrial dsRNA triggers antiviral signalling in humans 9.64
Chemotherapeutic drugs inhibiting Topoisomerase 1 activity inhibit TNF-induced inflammatory gene expression 9.48
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 9.47
Enhancement of Human B Cell Differentiation and Function in Lymph Nodes by the TLR9 Agonist MGN1703 9.41
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer [RNA-Seq] 9.29
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer 9.29
RNA-Seq analysis of HIF-2a-responsive genes in clear-cell renal cell carcinoma 9.26
Profiling of escape kinetics of viruses subjected to RNAi 9.24
Genomic deletion of malic enzyme 2 confers collateral lethality in pancreas cancer 9.15
RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 9.13
RNA-seq Profiles in RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 9.13
CDK12 mediated transcriptional regulation in U2OS cells 9.03
Mitotic stress is an integral part of the oncogene-induced senescence program that promotes multinucleation and cell cycle arrest 9.02
Induction of extracellular adenosine salvage and metabolic quiescence regulate the transitional to follicular B cell checkpoint in humans. 8.89
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia 8.79
FOXA1 Chromatin Binding is Regulated by LSD1-Mediated Demethylation 8.67
RNA-Seq with DHT induction and/or GSK treatment at 24, 48 hrs and 2 weeks 8.67
Generation of induced keratinocyte stem cells from human urine cells by defined transcription factors 8.62
CBFβ-MYH11 fusion blocks hematopoietic differentiation via repression of a GATA2 gene program 8.43
Subclonal cooperation drives metastasis through modulating local and systemic immune microenvironments 8.43
CD73 knockdown effect in pancreatic cancer cell lines 8.42
Cooperation of GRSF1 and the mitochondrial degradosome (hSuv3-PNPase complex) in degradation of mitochondrial RNA 8.39
Effect of BCL11B knockdown on transcriptome of human T-cell precursors 8.39
Genome-wide CRISPR-Cas9 screen identifies SLC1A3 as a key contributor to L-asparaginase Resistance in Solid tumors 8.31
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability 8.25
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability [ RNA-seq] 8.25
ETS family proteins bind glucocorticoid receptor: relevance for treatment of Ewing sarcoma 8.24
RNA-seq during MCF10A-ER-Src cell transformation and upon factor knockdowns 8.2
Genome-scale identification of transcription factors that mediate an inflammatory network during breast cellular transformation 8.2
Role of XRN2 ribonucleolytic activity in RNA metabolism 8.14
CHD1 loss sensitizes prostate cancer to DNA damaging therapy by promoting error-prone double-strand break repair 8.01
β-Caryophyllene Enhances the Transcriptional Upregulation of SREBP-dependent Lipid Biosynthesis in Breast Cancer Cells 8.01
Ebola virus (EBOV) infection of ARPE-19 cells 7.93
Transcriptome analysis of PC9 cells with gefitinib or/and hypoxia treatment and comparison with gefitinib resistant PC9 cells and ALDH positive PC9 cells 7.88
RNA Seq of HMVEC under hypoxia 7.86
Endothelial-AGO1-knockout (EC-AGO1-KO) mice and wild-type (WT) littermates 7.86
Transcriptional landscape changes during human embryonic stem cell derivation 7.85
Human blood CD1c⁺ dendritic cells encompass CD5-high and CD5-low subsets that differ significantly in phenotype, gene expression and functions 7.72
Integrating the Epigenome to Identify Novel Drivers of Hepatocellular Carcinoma 7.69
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer 7.64
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer [RNA-Seq] 7.64
RNA-seq in SUNE-1 cells after downregulation of DANCR expression 7.53
Expansion, in vivo-ex vivo cycling and genetic manipulation of primary human hepatocytes 7.46
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (nuclear RNA) 7.32
RNA sequencing, chromatin accesibility and ChIP seq analysis of BAP1 -/- human liver organoids 7.17
Transcriptome landscape of HeLa response upon triamcinolone acetonide 7.08
Gene expression from AsPC-1 cells treated with PTC596 and DMSO 7.04
RNA-Seq with and without RNase treatment in PCa cell lines 7.0
Metastasis in triple-negative breast cancer 6.98
Functional and genomic characterization of a xenograft model system for the study of metastasis in triple-negative breast cancer. 6.98
Long non-coding RNA profiling of human lymphoid progenitors reveals transcriptional divergence of B cell and T cell lineages 6.95
Neuronal Development And The Onset Of Electrical Activity In The Human Enteric Nervous System 6.93
CHCHD2 gene KO effect in iPSC drived motor neurons 6.92
Ribosome Incorporation into Somatic Cells Promotes Lineage Transdifferentiation towards Multipotency [RNA-Seq] 6.86
Ribosome Incorporation into Somatic Cells Promotes Lineage Transdifferentiation towards Multipotency 6.86
RNA-seq analysis of SLIRP knockdown with 1nM DHT in LNCaP cells 6.76
The effect of PPARG inhibition on human angiomyolipoma cells 6.73
Reducing the structure bias of RNA-Seq reveals a large number of non-annotated non-coding RNA 6.7
The RNA-binding protein RBM47 suppresses metastatic breast cancer progression 6.68
Human cells contain natural double-stranded RNAs with potential regulatory capacity 6.64
Time-Resolved Proteomics Extends Ribosome Profiling-Based Measurements of Protein Synthesis Dynamics 6.59
The role of CFTR in islet function 6.59
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification 6.53
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification [Mouse and Human RNA-seq and BS-seq] 6.53
Effect of Ro 08-2750 treatment on gene expression of human leukemia cell lines MOLM13 and K562 6.49
Loss of the Chr16p11.2 candidate gene QPRT leads to aberrant neuronal differentiation 6.49
hnRNP L protects mRNAs from nonsense-mediated mRNA decay 6.34
DHX36 is the missing link to understand RNA G-quadruplex structures, mRNA stability, and translation [RNA-seq] 6.24
Mesothelioma xenografts in nude mice: PBS treated versus pirfenidone treated 6.24
PSEN1ΔE9, APPswe and APOE4 confer disparate phenotypes in human iPSC-derived microglia 6.15
Transcriptional changes during naturally-acquired ZIKA Virus infection render dendritic cells highly conducive to viral replication 6.0
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 [3mRNA-seq] 5.97
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 5.97
High-resolution comparative analysis of great ape genomes 5.97
IRF1 regulates IFN dependent and independent gene expression 5.89
Differential expression analysis of RNA-seq data from melanocytes driven by tumor cell-derived exosomes 5.84
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis [RNA-Seq] 5.69
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis 5.69
Transcriptional differences between skin from patients with atopic dermatitis and control skin obtained from the healthy margins of Mohs surgery patients 5.58
Exploring ILF2 regulatory genes by next-generation sequencing 5.57
The ribonuclease activity of SAMHD1 is required for HIV-1 restriction 5.29
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 5.28
A map of gene expression in neutrophil-like cell lines 5.26
BET bromodomain proteins function as master transcription elongation factors independent of CDK9 recruitment [NET-seq] 5.25
Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer 5.11
Oligogenic inheritance of congenital heart disease involving a NKX2-5 modifier 5.02
Oligogenic inheritance of congenital heart disease involving a NKX2-5 modifier [human] 5.02
A systematic analysis of the time series gene expression in TGF-beta induced EMT by Next-generation sequencing 5.01
Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles 4.89
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [Toxin] 4.88
Transcriptome profiling of Cryptosporidium parvum infected lung and intestinal organoids 4.78
Transcriptomic analysis of the effect of trastuzumab in human iPSC-CMs 4.77
Truncation of LOC100288798 (SLC38A4-AS) lncRNA in human haploid KBM7 cell line 4.72
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk [RNA-seq] 4.65
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk 4.65
Vammin induces a highly efficient angiogenic response through VEGFR-2/NRP-1 and bypasses the regulatory function of VEGFR-1 4.56
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma 4.39
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma (RNA-Seq) 4.39
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 rescue] 4.38
Loss of Function Mutations in ETS2 Repressor Factor (ERF) Reveal a Balance Between Positive and Negative ETS Factors Controlling Prostate Oncogenesis [22PC RNA-seq] 4.29
Induction of Cardiomyocyte Proliferation [pz-822_human] 4.23
Regulation of Cell Cycle to Stimulate Adult Cardiomyocyte Proliferation and Cardiac Regeneration 4.23
Cis-SAGe fusion RNAs in transcription splicing factors knocking-down 293T cells 4.19
RNA-Seq in PWS iPSC-derived neurons 4.07
Heterogeneous maintenance of human tissue resident memory T cells based on efflux capacities 3.9
Effects of transcription on genome - nuclear lamina interactions: RNA-seq data 3.85
Effects of transcription on genome - nuclear lamina interactions 3.85
Canonical and non-canonical regulatory roles of androgen receptor variant 7 in prostate cancer 3.71
Effect of circPTPRM on the biological behaviors of hepatocellular carcinoma cells in vitro and its clinical significance. 3.64
RNA-seq of synchronized S phase or G2 phase cells treated with an ATR inhibitor 3.59
Impeding transcription of expanded microsatellite repeats by deactivated Cas9 3.43
Identification of a Cell-of-Origin for Fibroblasts Comprising the Fibrotic Reticulum in Idiopathic Pulmonary Fibrosis 3.35
An interaction with Ewing's sarcoma breakpoint protein EWS defines the specific oncogenic mechanism of ETS factors rearranged in prostate cancer 3.3
Inhibition of H3K4 demethylation induces autophagy in cancer cell lines 3.3
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 3.15
NR4A1 Inhibition Synergizes with Ibrutinib in Killing Mantle Cell Lymphoma Cells 3.12
IL-6 augments IL-4-induced polarization of primary human macrophages through synergy of STAT3, STAT6 and BATF transcription factors 3.09
Transcriptome-wide analysis to determine miR-200a targets in melanoma cell lines 3.09
Oncolytic reactivation of KSHV as a therapeutic approach for primary effusion lymphoma: RNA-sequencing of PEL cell lines during KSHV reactivation 2.99
RNA sequencing of GLO1-depleted MDA-MB-231 breast cancer cells 2.97
Gene Expression Analysis of HUVEC Seeded rBEL Contructs at Low and High Phases of Glucose Consumption 2.9
Transcriptome Analysis Reveals Distinct Responses to Physiologic versus Toxic Manganese Exposure in Human Neuroblastoma Cells 2.88
Specific labeling of stem cell activity in human colorectal organoids using an ASCL2-responsive minigene 2.85
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation II 2.81
Loss of CREBBP results in H3K27Ac loss at enhancers and gene expression repression in lymphoma cells 2.76
Loss of CREBBP results in gene expression repression in lymphoma cells 2.76
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders 2.7
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders [lnc-Nr2f1 overexpression] 2.7
Study of dynamic transcriptome profiling in DNA damage-induced cellular senescence and transient cell-cycle arrest 2.67
Mutually Exclusive CBC-Containing Complexes Contribute to RNA Fate. 2.67
6mer seed toxicity in tumour suppressive microRNAs 2.63
Expression analysis of genes modulated after knock-down of lncRNA CHROME. 2.54
mRNA gene expression profiling in a human AML cell line treated with small molecule inhibitors that impact different RNA polymerase transcription complexes, or their combination, in comparison to a global DNA-damaging anthracycline compound 2.44
The IMiDs, through loss of Ikaros and Aiolos, primes myeloma cells for daratumumab mediated killing by upregulation of CD38 2.4
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells (RNA-Seq) 2.36
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells 2.36
Transcriptome profiling of A2M treated A549 Cell Line Samples 2.35
Transcriptomic analysis of inter- and intra-patient variation in human iPSC cardiomyocytes: Platform for precision medicine to predict drug toxicity 2.33
RUNX1 mutations lead to a myeloid differentiation block by altering the RUNX1 transcriptional program (RNA-Seq) 2.31
RUNX1 mutations lead to a myeloid differentiation block by altering the RUNX1 transcriptional program 2.31
GATA2 promotes hematopoietic development and represses cardiac differentiation of human mesoderm 2.09
Genome-Wide Transcriptional Regulation Mediated By Biochemically Distinct Forms of SWI/SNF 2.02
Combinatorial Regulation Mediated by Biochemically Distinct Forms of SWI/SNF [RNA-Seq] 2.02
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection 1.91
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection [RNA-seq] 1.91
p63 controls the enhancer landscape during keratinocyte differentiation 1.85
RNA sequencing of Asthmatic Human Airway Smooth Muscle Cells I 1.72
A stably self-renewing adult blood-derived induced neural stem cell exhibiting patternability and epigenetic rejuvenation 1.66
RNA-Seq analysis of human colorectal cancer with liver metastasis 1.48
Analysis of gene expression in SKOV3 ovarian cancer cells after knockdown of the long non-coding RNA DNM3OS 1.48
UBL5 is essential for pre-mRNA splicing and sister chromatid cohesion in human cells 1.37
Isolation of highly enriched cardiac mesoderm from differentiating human embryonic stem cells 1.36
CD13 and ROR2 permit isolation of highly enriched cardiac mesoderm from differentiating human embryonic stem cells 1.36
C9/ALS Human Embryonic Stem Cells and C9/ALS Induced Pluripotent Stem Cells 1.33
The MEF2B Regulatory Network - RNA-seq data 1.33
The MEF2B Regulatory Network 1.33
Transcriptional response of human endocervical epithelial A2EN cells to infection with wild-type or CpoS-deficient Chlamydia trachomatis L2/434/Bu 1.23
Primate-specific gene TMEM14B promotes cortical expansion and folding 1.22
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth [RNA-Seq] 1.22
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth 1.22
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 1.19
Zone dependent distinctive gene expression profile of the normal human liver tissue 1.11
Hepatic transcriptome of pediatric hepatoblastoma. 1.1
Genome-wide search for differentially expressed RNAs responsible for the effects induced by Ebola virus replication and transcription 1.06
Maternal-biased H3K27me3 correlates with paternal-specific gene expression in the human morula 1.04
Single cell transcriptomics analysis of induced pluripotent stem cell-derived cortical neurons reveals frequent dual layer identity 0.98
Effect of SHP2 inhibition on hepatic stellate cell transcriptome. 0.95
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes 0.84
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes [RNA-seq] 0.84
RelA mutants 'reconstituted' and cell cycle synchronized HCT116 Colorectal Cancer Cells 0.82
The impact of oil spill to lung health – insights from an RNA-seq study of human airway epithelial cells 0.77
Whole Transcriptomic Sequencing of Metastatic Castration Resistant Prostate Cancer Samples 0.73
Transcriptomic Analysis Of circRNAs/miRNAs/mRNAs upon Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection 0.72
Transcriptome analysis of fetal Klinefelter testis tissue samples compared to controls 0.57
KRASG12C inhibition produces a driver-limited state revealing collateral dependencies 0.57
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis [Quant-Seq] 0.53
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis 0.53
Muscleblind-like 1 suppresses breast cancer metastatic colonization and stabilizes metastasis suppressor transcripts 0.52
MBNL1-dependent modulation of gene expression in MDA-MB-231 breast cancer cells 0.52
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 & MCM7 0.47
Cooperative and Antagonistic Transcriptional Regulation by BRG/BRM [RNA-seq] 0.47
Co-regulation of transcription by BRG1 and Brm, two mutually exclusive SWI/SNF ATPase subunits 0.47
Human Treg IFNg/IL-10 subpopulations 0.45
Trascriptome of thyroid cancer-induced macrophages 0.44
System-wide profiling of RNA-binding proteins uncovers key regulators of virus infection 0.38
Deciphering H3K4me3 Broad Domains Associated With Gene Regulatory Networks and Conserved Epigenomic Landscapes in the Human Brain [RNA-Seq] 0.37
Deciphering H3K4me3 Broad Domains Associated With Gene Regulatory Networks and Conserved Epigenomic Landscapes in the Human Brain 0.37
Transcriptome analysis upon C6orf203 silencing 0.35
An intramolecular salt bridge linking TDP43’s RNA recognition motifs dictates RNA binding, protein stability and TDP43-dependent neurodegeneration 0.35
Human islets of varying quality: the good, the (not so) bad and the ugly 0.28
Determining mRNA half-lives on a transcriptome-wide scale 0.26
Screening in Human Cardiac Organoids Identifies a Requirement for the Mevalonate Pathway in Cardiomyocyte Proliferation 0.22
RNA-seq identifies novel lncRNAs involved in vascular smooth muscle cell proliferation 0.22
An epigenetic mark of polycomb response elements implemented by Trx/MLL/COMPASS 0.21
RNA-seq and small RNA-seq from WT and ADAR1 knockdown H9 lines and their differentiation to specific types of neurons 0.2
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. 0.19
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. [RNA-Seq] 0.19
Epigenome Editing by CRISPR/Cas9 Repressors for Silencing of Distal Regulatory Elements 0.16
A histone H3.3 Lysine 36 Trimethylation Reader Connects Chromatin to Regulated Pre-mRNA Processing 0.06
RNA-sequencing of the brain transcriptome implicates dysregulation of neuroplasticity, circadian rhythms, and GTPase binding in bipolar disorder 0.04
Genes encoding cognate receptors for IRI-related recipient cytokines are expressed in donor livers 0.02
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 2) 0.02


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation